Clinical, Microbiological, and Economic Benefit of a Change in Antibiotic Prophylaxis for Cardiac Surgery
- 1 July 2002
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 23 (7) , 402-404
- https://doi.org/10.1086/502074
Abstract
Clinical, Microbiological, and Economic Benefit of a Change in Antibiotic Prophylaxis for Cardiac Surgery - Volume 23 Issue 7 - Denis Spelman, Glenys Harrington, Phil Russo, S. WesselinghKeywords
This publication has 7 references indexed in Scilit:
- Cost of surgical site infections following coronary artery bypass surgeryAnz Journal of Surgery, 2001
- RISK FACTORS FOR SURGICAL WOUND INFECTION AND BACTERAEMIA FOLLOWING CORONARY ARTERY BYPASS SURGERYAnz Journal of Surgery, 2000
- Comparison of Vancomycin and Cefuroxime for Infection Prophylaxis in Coronary Artery Bypass SurgeryInfection Control & Hospital Epidemiology, 1998
- Risk Factors Associated with Vancomycin-Resistant Enterococcus faecium Infection or Colonization in 145 Matched Case Patients and Control PatientsClinical Infectious Diseases, 1996
- CDC Definitions of Nosocomial Surgical Site Infections, 1992: A Modification of CDC Definitions of Surgical Wound InfectionsInfection Control & Hospital Epidemiology, 1992
- Antibiotic prophylaxis for cardiothoracic operationsThe Journal of Thoracic and Cardiovascular Surgery, 1992
- Rifampin blood and tissue levels in patients undergoing cardiac valve surgeryAntimicrobial Agents and Chemotherapy, 1982